Apollo Hospitals Enterprise Limited (APOLLOHOSP) — Financial Results | 12 August 2026(4 announcements)

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Financial Results 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Apollo Hospitals reported Q1 FY27 revenue of ₹70,435 million and PAT of ₹5,805 million with 21% and 34% YoY growth respectively.
🔄 What Changed
Revenue grew 21% YoY to ₹70,435 million, PAT increased 34% to ₹5,805 million, EBITDA rose 28% to ₹10,920 million, and EBITDA margin improved to 15.5% post-ESOP adjustments.
🔮 What's Next
Company projects annualized revenue of ₹250 billion by Q4 FY27 and an EBITDA margin range of 6.5% to 7.0% by then.
💡 Investor Takeaway
Strong growth in revenue, PAT, and EBITDA signals operational momentum, but margin expansion may face pressure from ongoing digital investments and restructuring costs.

Apollo Hospitals reported consolidated revenue of ₹70,435 million for Q1 FY27, up 21% year-on-year, with PAT rising 34% to ₹5,805 million. EBITDA reached ₹10,920 million, reflecting 28% growth, driven by 22% revenue growth in healthcare services and 31% expansion in diagnostics. The company added 5 new hospitals, bringing total hospitals to 48 with 8,352 beds, and expanded its digital health platform to 49 million+ registrations and 15,330+ doctors. Gross margin improved to 24.5%, and EBITDA margin stood at 15.5% post-ESOP adjustments. Strategic moves include a MoU for electric air ambulances and plans to restructure into a new Indian-owned entity.

2 Financial Results 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Apollo Hospitals announces Q1 FY27 results and proposes demerger into a new entity for pharmacy and digital businesses.
🔄 What Changed
Revenue grew 20% YoY to ₹70,435 million; net profit up 3%; EBITDA margin at 8.2%; 5 new hospitals commissioned; digital health revenue up 24% excluding closure; diagnostics revenue up 31%; digital cash loss reduced to ₹97 million.
🔮 What's Next
Target annualized revenue of INR 250 bn by Q4 FY27 with EBITDA margin of 6.5%-7.0% for the combined entity.
💡 Investor Takeaway
The demerger aims to unlock value by separating pharmacy and digital operations, potentially improving focus and valuation for each segment.

Apollo Hospitals reported Q1 FY27 revenue of ₹70,435 million, up 20% YoY, with net profit growing 3% and EBITDA margin at 8.2%. The company commissioned 5 new hospitals, expanded its digital health platform to 49 million+ users, and saw diagnostics revenue rise 31%. It also outlined plans to demerge and merge key businesses into a new entity targeting INR 250 bn annualized revenue by Q4 FY27.

3 Financial Results 🔴 High Importance ✨ Positive 📄 PDF
MetricValue
Revenue₹27,032 Cr
Net Profit (PAT)₹3,852 Cr
📢 Key Event
Board approved merger of Apollo Hospitals North Limited and combination of Apollo Health and Lifestyle Limited with Kids Clinic India Limited.
🔄 What Changed
Revenue grew 21% YoY to Rs 7,043 Crore; PAT at Rs 581 Crore; EBITDA up 28% YoY to Rs 1,092 Crore; merger and combination proposals approved.
🔮 What's Next
Add over 5,800 beds in five years; expand to Sarjapur and Indore; complete merger and combination pending regulatory approvals.
💡 Investor Takeaway
The company is scaling hospital capacity and pursuing strategic combinations to drive growth, supported by strong financial performance and operational momentum.

Apollo Hospitals Enterprise Limited reported consolidated revenue of Rs 7,043 Crore for Q1 FY27, up 21% YoY, with PAT at Rs 581 Crore and EBITDA at Rs 1,092 Crore, up 28% YoY. The company approved a merger of Apollo Hospitals North Limited and a combination of Apollo Health and Lifestyle Limited with Kids Clinic India Limited, valued at Rs 15,500 million enterprise value. It also announced plans to add over 5,800 beds in five years and expand into new locations including Sarjapur and Indore. The board approved a Business Framework Agreement with Apollo Healthco Limited, pending regulatory and shareholder approvals. The filing includes auditor review confirmation of no material misstatements and mentions ongoing legal challenges with interim court relief.

4 Financial Results 🔴 High Importance ✨ Positive 📄 PDF
MetricValue
Revenue₹70,923 Cr
Net Profit (PAT)₹3,852 Cr
📢 Key Event
Board approved Q1 FY27 financial results and strategic initiatives including bed expansion and merger plans.
🔄 What Changed
Revenue grew 21% YoY to Rs 7,043 Crore; PAT rose to Rs 581 Crore; EBITDA increased 28% YoY to Rs 1,092 Crore; proposed merger with Kids Clinic India Limited at Rs 15,500 million enterprise value.
🔮 What's Next
Add over 5,800 beds in five years; launch new hospitals in Sarjapur, Indore, and Guwahati; complete merger with Kids Clinic India Limited subject to CCI approval.
💡 Investor Takeaway
Strong revenue and profit growth with aggressive expansion plans signal future earnings potential but depend on regulatory approvals and execution of merger.

Apollo Hospitals Enterprise Limited reported consolidated revenue of Rs 7,043 Crore for Q1 FY27, up 21% YoY, with PAT at Rs 581 Crore and EBITDA at Rs 1,092 Crore, up 28% YoY. The company announced plans to add over 5,800 beds in five years and launch new hospitals in Sarjapur, Indore, and Guwahati. It also disclosed a proposed merger with Kids Clinic India Limited involving an enterprise value of Rs 15,500 million and regulatory approvals from NSE and BSE. The press release includes details of auditor appointments, stock option grants, and transfer of a consumer goods business.

About Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,16,213.95 Cr P/E: 64.5 ROE: 21.9% ROCE: 20.5%

View full APOLLOHOSP stock details →

📡 Get AI alerts when APOLLOHOSP files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APOLLOHOSP — Free

📊 More APOLLOHOSP filings

See all APOLLOHOSP filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when APOLLOHOSP files new disclosures

Track APOLLOHOSP filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track APOLLOHOSP — Free

Free account · 2 AI queries/day